The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant stereotactic radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV).
 
Tian Zhang
Leadership - Archimmune Therapeutics (I); Capio BioSciences (I)
Stock and Other Ownership Interests - Archimmune Therapeutics (I); Capio Biosciences (I); Nanorobotics (I)
Honoraria - Aptitude Health; Clinical Care Options; Curio Science; Mashup Media; MJH Life Sciences; Peerview
Consulting or Advisory Role - Aravive; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Gilead Sciences; Janssen; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Sanofi/Aventis; Seagen; Xencor
Research Funding - ALX Oncology (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Janux Therapeutics (Inst); Loxo/Lilly (Inst); OncoC4; Pfizer (Inst); Tempus (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
Travel, Accommodations, Expenses - Bayer
Other Relationship - ASCO; Kidney Cancer Association; KidneyCan; Myrovlytis Trust; Winn Foundation
 
Solomon Woldu
Consulting or Advisory Role - Urogen pharma
 
Minjae Lee
No Relationships to Disclose
 
Qian Qin
Honoraria - MashupMedia; MJH Life Sciences
Consulting or Advisory Role - Exelixis
 
Suzanne Cole
Research Funding - Merck (Inst)
 
Waddah Arafat
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Basilea (Inst); Merck (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Changchuan Jiang
Honoraria - MJH Life Sciences
 
Jue Wang
No Relationships to Disclose
 
Kevin Courtney
Consulting or Advisory Role - Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Celgene/Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); DualityBio (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Janssen Research & Development (Inst); Lilly (Inst); Myovant Sciences (Inst); Novartis (Inst); Pfizer (Inst); Stemline Therapeutics (Inst); Surface Oncology (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Andrew DeVilbiss
No Relationships to Disclose
 
Molly McGuire
No Relationships to Disclose
 
Raquibul Hannan
No Relationships to Disclose
 
Daniel Yang
No Relationships to Disclose
 
Aurelie Garant
Research Funding - Reflexion Medical (Inst); Teleflex Medical (Inst)
 
Isamu Tachibana
No Relationships to Disclose
 
Kris Gaston
No Relationships to Disclose
 
Andrew Wang
Leadership - Archimmune Therapeutics; Capio BioSciences; Novartis (I)
Stock and Other Ownership Interests - Archimmune Therapeutics; Archimmune Therapeutics; Capio BioSciences
Consulting or Advisory Role - Aptitude Health (I); Aravive (I); AVEO (I); Bayer (I); Capio BioSciences; Dendreon (I); Eisai (I); Gerson Lehrman Group; Janssen (I); Johnson & Johnson Innovation; Kidney Cancer Association (I); Merck KGaA (I); Mirati Therapeutics (I); MJH Associates (I); Peerview (I); PlatformQ Health (I); QED Therapeutics (I); Regeneron (I); Sanofi/Aventis (I); Seagen (I)
Research Funding - Archimmune Therapeutics; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Antigen capturing nanoparticles technology licensed to Archimmune Therapeutics; Biomatrix patent licensed to PhoenixSongs
Travel, Accommodations, Expenses - Exelixis (I); Genentech (I); Pfizer (I); Sanofi (I)
 
Vitaly Margulis
Research Funding - Merck (Inst)
 
Yair Lotan
Stock and Other Ownership Interests - CAPs medical; Nanorobotics; Phinomics; trigone pharma; Uroviu; vesica health; Vessi Medical; Virtuoso Therapeutics
Consulting or Advisory Role - Abbvie; Ambu; AstraZeneca; Aura Biosciences; BMS; caps medical; Cleveland Diagnostics; Convergent Genomics; Fergene; ImmunityBio; Janssen; Merck; Nanogen Biopharmaceutical; Nanorobotics; nrx pharmaceuticals; Nucleix; pacific edge; phinomics; Photocure; Seagen; Stimit; trigone pharma; Urogen pharma; uroviu; verity pharmaceuticals; Vessi Medical; virtuoso surgical; Xcures
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst); storz (Inst)
 
Neil Desai
Consulting or Advisory Role - Boston Scientific; Novartis; Telix Pharmaceuticals
Speakers' Bureau - Ultimate Medical Academy
Research Funding - Boston Scientific (Inst); Reflexion Medical (Inst); Reflexion Medical (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer
(OPTIONAL) Uncompensated Relationships - Bayer